Andere Sprachen 9 Meters Biopharma, Inc.

Aktien

Verzögert OTC Markets Andere Börsenplätze 15:30:05 02.05.2024			% 5 Tage	% 1. Jan.
0,000001 ^USD	0,00 %		0,00 %	0,00 %

2023	Illumina senkt Jahresprognose für Gewinn, da Biotech-Finanzierungsprobleme andauern	RE
2023	Illumina senkt Jahresgewinnprognose	RE

North American Morning Briefing : Tech in Focus on -2-	25.03.
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29.11.
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27.11.
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07.11.
North American Morning Briefing : Stocks Look to -2-	06.11.
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02.11.
Celiac Disease Pipeline, Clinical Trials, FDA Approvals, and Emerging Drugs 2023 (Updated)	02.10.23
North American Morning Briefing : Stock Futures -2-	22.09.23
North American Morning Briefing : Mood Seen Buoyed -2-	15.09.23
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08.09.23
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01.09.23
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25.08.23
North American Morning Briefing : China Trouble Hits Sentiment	18.08.23
North American Morning Briefing : Stock Futures -2-	11.08.23
Illumina cuts annual profit forecast as biotech funding woes linger	09.08.23
Illumina cuts annual profit forecast	09.08.23
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25.07.23
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21.07.23
Drug developer 9 Meters Biopharma files for bankruptcy protection	18.07.23
9 Meters Biopharma, Inc. Filed for Bankruptcy	17.07.23

Keine Ergebnisse zu dieser Suche